Inflammatory Bowel Disease Registry in Daegu-Gyeongbuk

NCT ID: NCT02193464

Last Updated: 2021-01-12

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

100 participants

Study Classification

OBSERVATIONAL

Study Start Date

2014-09-30

Study Completion Date

2026-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to investigate the incidence and natural course of inflammatory bowel disease in the southeastern area of Korea.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Idiopathic Chronic Inflammatory Bowel Disease

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

inflammatory bowel disease

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Clinical diagnosis of inflammatory bowel disease including Crohn's disease and ulcerative colitis
* Followed up for at least 6 months for the correct diagnosis

Exclusion Criteria

* Patients who do not live in Daegu-Gyeongbuk province
Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Yeungnam University Hospital

OTHER

Sponsor Role collaborator

Daegu Catholic University Medical Center

OTHER

Sponsor Role collaborator

DongGuk University

OTHER

Sponsor Role collaborator

Kyungpook National University Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Eun Soo Kim, MD, PhD

Professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Eun Soo Kim, MD, PhD

Role: PRINCIPAL_INVESTIGATOR

Keimyung University School of Medicine

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Keimyung University Dongsan Medical Center

Daegu, , South Korea

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

South Korea

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Eun Soo Kim, MD. PhD

Role: CONTACT

+82-53-250-7088

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Eun Soo Kim, MD, PhD

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

EPICODE

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.